DUBLIN--(BUSINESS WIRE)--Jul 9, 2019--

This new report United Kingdom Diabetes Market Report: 2019 - 2024 provides an analytical and statistical insight into the UK diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in UK. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the UK diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the UK diabetes market in any form.

What we have achieved in this report:

Comprehensive situation analysis of the UK diabetes epidemiology and its dynamics:

Focus of the Analysis:

Historical, current and future prevalence of diabetes in UK

Historical, current and future prevalence of type-1 and type-2 diabetes in UK

Historical, current and future prevalence of diabetes in the urban and rural regions in UK

Historical, current and future prevalence of diabetes among males and females in UK

Historical, current and future prevalence of diabetes among various age groups in UK

Historical, current and future diagnosis rates for diabetes in UK

Historical, current and future drug treatment rates for diabetes in UK

Comprehensive situation analysis of the UK Oral Antidiabetics market and its dynamics:

Focus of the Analysis:

Performance of the Oral Antidiabetics market in UK

Performance of key classes

Performance of key players

Market outlook

Comprehensive situation analysis of the UK Insulin market and its dynamics:

Focus of the Analysis:

Performance of the Insulin market in UK

Performance of key classes

Performance of key players

Market outlook

Key Topics Covered:

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study

2.2 Stakeholders

2.3 Data Sources

2.3.1 Primary Sources

2.3.2 Secondary Sources

2.4 Market Estimation

2.4.1 Bottom-Up Approach

2.4.2 Top-Down Approach

2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Diabetes Disease Overview

5.1 What is Diabetes?

5.2 Diabetes Diagnosis and Treatment

5.2.1 Diagnosis

5.2.2 Treatment

5.3 Diabetes Complications

6 UK Diabetes Epidemiology

6.1 Diabetes Population and Prevalence Rates

6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)

6.3 Population and Prevalence Rates by Region

6.4 Population and Prevalence Rates by Gender

6.5 Population and Prevalence Rates by Age Group

7 UK Diabetes Market

7.1 Market Overview

7.2 Market Performance

7.3 Market Forecast

7.4 SWOT Analysis

7.4.1 Overview

7.4.2 Strengths

7.4.3 Weaknesses

7.4.4 Opportunities

7.4.5 Threats

7.5 Value Chain Analysis

7.6 Porter's Five Forces Analysis

7.6.1 Overview

7.6.2 Bargaining Power of Buyers

7.6.3 Bargaining Power of Suppliers

7.6.4 Degree of Competition

7.6.5 Threat of New Entrants

7.6.6 Threat of Substitutes

7.7 Market Breakup by Segment

7.7.1 UK Oral Antidiabetics Market

7.7.1.1 Historical Market Trends

7.7.1.2 Market Breakup by Class

7.7.1.3 Market Shares of Key Players

7.7.1.4 Market Forecast

7.7.2 UK Insulin Market

7.7.2.1 Historical Market Trends

7.7.2.2 Market Breakup by Class

7.7.2.3 Market Shares of Key Players

7.7.2.4 Market Forecast

8 Competitive Landscape

8.1 Competitive Structure

8.2 Profiles of Key Players

For more information about this report visit https://www.researchandmarkets.com/r/k4frxq

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Endocrine and Metabolic Disorders Drugs,Diabetes Drugs

KEYWORD: UNITED KINGDOM EUROPE

INDUSTRY KEYWORD: HEALTH DIABETES

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 07/09/2019 06:09 AM/DISC: 07/09/2019 06:09 AM

Copyright Business Wire 2019.